Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs

Journal of General Virology

Volumn 80, Issue 8, 1999, Pages 1965-1974

  Szilvay, Anne Marie ^a   Bøe, Stig Ove ^a   Kalland, Karl Henning ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY; RNA SPLICING; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032772282     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-8-1965     Document Type: Article

References (69)

1. Åkerblom, L., Hinkula, J., Broliden, P. A., Makitalo, B., Fridberger, T., Rosen, J., Viliacres-Eriksson, M., Morein, B. & Wahren, B. (1990). Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS 4, 953-960.
2. Arrigo, S. J. & Chen, I. S. Y. (1991). Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr and env/vpu 2 RNAs. Genes & Development 5, 808-819.
3. Benko, D. M., Schwartz, S., Pavlakis, G. N. & Felber, B. K. (1990). A novel human immunodeficiency virus type 1 protein, Tev, shares sequences with Tat, Env, and Rev proteins. Journal of Virology 64, 2505-2518.
4. Bøe, S. O., Bjømdal, B., Røsok, B., Szilvay, A. M. & Kalland, K.-H. (1998). Sub-cellular localization of human immunodeficiency virus type 1 RNAs, Rev and the splicing factor SC-35. Virology 244, 473-482.
5. Bogerd, H. & Greene, W. C. (1993). Dominant negative mutants of human T-cell leukemia virus type 1 Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. Journal of Virology 67, 2496-2502.
6. Bogerd, H. P., Fridell, R. A., Madore, S. & Cullen, B. R. (1995). Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82, 485-494.
7. Böhnlein, E., Berger, J. & Hauber, J. (1991). Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. Journal of Virology 65, 7051-7055.
8. Chang, D. D. & Sharp, P. A. (1989). Regulation by HIV Rev depends upon recognition of splice sites. Cell 59, 789-795.
9. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-159.
10. Cochrane, A. W., Perkins, A. & Rosen, C. A. (1990). Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. Journal of Virology 64, 881-885.
11. Cochrane, A. W., Jones, K. S., Beidas, S., Dillon, P. J., Skalka, A. M. & Rosen, C. A. (1991). Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. Journal of Virology 62, 5305-5313.
12. Cullen, B. R. (1992). Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiological Reviews 56, 375-394.
13. Cullen, B. R., Hauber, J., Campbell, K., Sodroski, J. G., Haseltine, W. A. & Rosen, C. A. (1988). Subcellular localization of the human immunodeficiency virus trans-acting art gene product. Journal of Virology 62, 2498-2501.
14. D'Agostino, D. M., Felber, B. K., Harrison, J. E. & Pavlakis, G. N. (1992). The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Molecular and Cellular Biology 12, 1375-1386.
15. Dayton, A. I., Terwilliger, E. F., Potz, J., Kowalski, M., Sodroski, J. G. & Haseltine, W. A. (1988). Cis-acting sequences responsive to the Rev gene product of the human immunodeficiency virus. Journal of AIDS 1, 441-452.
16. Dayton, E. T., Douglas, M., Powell, D. & Dayton, A. (1989). Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. Science 246, 1625-1629.
17. Emerman, M., Vazeux, R. & Peden, K. (1989). The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57, 1155-1165.
18. Favaro, J. P. & Arrigo, S. J. (1997). Characterization of Rev function using subgenomic and genomic constructs in T and COS cells. Virology 228, 29-38.
19. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T. & Pavlakis, G. N. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proceedings of the National Academy of Sciences, USA 86, 1495-1499.
20. Fischer, U., Meyer, S., Teufel, M., Heckel, C., Lührmann, R. & Rautmann, G. (1994). Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO Journal 13, 4105-4112.
21. Fischer, U., Huber, J., Bolens, W. C., Mattaj, I. W. & Luhrmann, R. (1995). The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82, 475-483.
22. Green, M. R. (1993). Molecular mechanisms of Tat and Rev. AIDS Research Reviews 3, 41-55.
23. Hammarskjöld, M. L., Li, H., Rekosh, D. & Prasad, S. (1994). Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron. Journal of Virology 68, 951-958.
24. Haseltine, W. A. (1991). Regulation of HIV-1 replication. In Genetic Structure and Regulation of HIV-1, pp. 1-42. Edited by W. A. Haseltine & F. Wong-Staal. New York: Raven Press.
25. Hope, T. J., Huang, X., McDonald, D. & Parslow, T. G. (1990). Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proceedings of the National Academy of Sciences, USA 87, 7787-7791.
26. Hope, T. J., Klein, N. P., Elder, M. E. & Parslow, T. G. (1992). Trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes. Journal of Virology 66, 1849-1855.
27. Huang, Y. & Carmichael, G. C. (1997). The mouse histone H2a gene contains a small element that facilitates cytoplasmic accumulation of intronless gene transcripts and of unspliced HIV-1 related mRNAs. Proceedings of the National Academy of Sciences, USA 94, 10104-10109.
28. Huang, Y., Wimler, K. M. & Carmichael, G. C. (1999). Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing. EMBO Journal 18, 162-1652.
29. Kalland, K. H., Langhoff, E., Bos, H. J., Göttlinger, H. & Haseltine, W. A. (1991). Rex-dependent nucleolar accumulation of HTLV-I mRNA. New Biologist 3, 389-397.
30. Kalland, K. H., Szilvay, A. M., Brokstad, K. A., Sætrevik, W. & Haukenes, G. (1994a). The human immunodeficiency virus type 1 (HIV-1) Rev protein shuttles between the cytoplasm and nuclear compartments. Molecular and Cellular Biology 14, 7436-7444.
31. Kalland, K. H., Szilvay, A. M., Langhoff, E. & Haukenes, G. (1994b). Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm. Journal of Virology 68, 1475-1485.
32. Kjems, J. & Sharp, P. A. (1993). The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. Journal of Virology 67, 4769-4776.
33. Kjems, J., Frankel, A. D. & Sharp, P. A. (1991 a). Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. Cell 67, 169-178.
34. Kjems, J., Brown, M., Chang, D. D. & Sharp, P. A. (1991 b). Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev responsive element. Proceedings of the National Academy of Sciences, USA 88, 683-687.
35. Kjems, J., Calnan, B. J., Frankel, A. D. & Sharp, P. A. (1992). Specific binding of a basic peptide from HIV-1 Rev. EMBO Journal 11, 1119-1129.
36. Lu, X., Heimer, J., Rekosh, D. & Hammarskjöld, M. L. (1990). U1 small nuclear RNA plays a direct role in the formation of rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proceedings of the National Academy of Sciences, USA 87, 7598-7602.
37. Madore, S. J., Tiley, L. S., Malim, M. M. & Cullen, B. R. (1994). Sequence requirements for Rev multimerization in vivo. Virology 202, 186-194.
38. Maldarelli, F., Martin, M. A. & Strebel, K. (1991). Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. Journal of Virology 65, 5732-5743.
39. Malim, M. H. & Cullen, B. R. (1991). HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65, 241-248.
40. Malim, M. H. & Cullen, B. R. (1993). Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Molecular and Cellular Biology 13, 6180-6189.
41. Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V. & Cullen, B. R. (1989 a). The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
42. Malim, M. H., Böhnlein, S., Hauber, J. & Cullen, B. R. (1989 b). Functional dissection of the HIV-1 Rev transactivator - derivation of a trans-dominant repressor of Rev function. Cell 58, 205-214.
43. Malim, M. H., Tiley, L. S., McCarn, D. F., Rusche, J. R., Hauber, J. & Cullen, B. R. (1990). HIV-1 structural gene expression requires binding of the rev trans-activator to its RNA target sequence. Cell 60, 675-683.
44. Malim, M. H., McCarn, D. F., Tiley, L. S. & Cullen, B. R. (1991). Mutational definition of the human immunodeficiency virus type 1 rev activation domain. Journal of Virology 65, 4248-4254.
45. Mermer, B., Felber, B. K., Campbell, M. & Pavlakis, G. N. (1990). Identification of trans-dominant HIV-1 Rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Research 18, 2037-2044.
46. Meyer, B. E. & Malim, M. H. (1994). The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes & Development 8, 1538-1547.
47. Misteli, T., Caceres, J. F. & Spector, D. L. (1997). The dynamics of a pre-mRNA splicing factor in living cells. Nature 387, 523-527.
48. Nosaka, T., Takamatsu, T., Miyazaki, Y., Sano, K., Sato, A., Kubota, S., Sakurai, M., Ariumi, Y., Nakai, M., Fujita, S. & Hatanaka, M. (1993). Cytotoxic activity of Rev protein of human immunodeficiency virus type 1 by nucleolar dysfunction. Experimental Cell Research 209, 89-102.
49. Olsen, H. S., Cochrane, A. W., Dillon, P. J., Nalin, C. M. & Rosen, C. A. (1990). Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes & Development 4, 1357-1364.
50. Ossareth-Nazari, B., Bachelerie, F. & Dargemont, C. (1997). Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278, 141-144.
51. Richard, N., Iacampo, S. & Cochrane, A. (1994). HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology 204, 123-131.
52. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. & Haseltine, W. A. (1988). Intragenic cis-acting art-gene-responsive sequences of the human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 85, 2071-2075.
53. Ruhl, M., Himmelspach, M., Bahr, G. M., Hammerschmid, F., Jaksche, H., Wolff, B., Aschauer, H., Farrington, G. K., Probst, H., Bevec, D. & Hauber, J. (1993). Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. Journal of Cell Biology 123, 1309-1320.
54. Salfeld, J., Gottlinger, H. G., Sia, R., Park, R., Sodroski, J. G. & Haseltine, W. A. (1990). A tripartite HIV-1 Tat-Env-Rev fusion protein. EMBO Journal 9, 965-970.
55. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1992). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. Journal of Virology 66, 150-159.
56. Sodroski, J., Goh, W. C., Rosen, C. A., Dayton, A., Terwilliger, E. & Haseltine, W. A. (1986). A second post-transcriptional activator gene required for HTLV-III replication. Nature 321, 412-417.
57. Solomin, L., Felber, B. K. & Pavlakis, G. N. (1990). Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1. Journal of Virology 64, 6010-6017.
58. Stauber, R., Gaitanaris, G. A. & Pavlakis, G. N. (1995). Analysis of trafficking and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology 213, 439-449.
59. Stauber, R., Alfonina, E., Gulnik, S., Erickson, J. & Pavlakis, G. N. (1998). Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells. Virology 251, 38-48.
60. Stutz, F. & Rosbash, M. (1994). A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation. EMBO Journal 13, 4096-4104.
61. Sundquist, V. A., Albert, J., Ohlson, E., Hinkula, J., Fenyø, E. M. & Wahren, B. (1989). Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. Journal of Medical Virology 29, 170-175.
62. Szilvay, A. M., Brokstad, K. A., Kopperud, R., Haukenes, G. & Kalland, K. H. (1995). Nuclear export of the nucleocytoplasmatic shuttle protein HIV-1 Rev is mediated by its activation domain and is blocked by transdominant negative mutants. Journal of Virology 69, 3315-3323.
63. Szilvay, A. M., Brokstad, K. A., Bøe, S. O., Haukenes, G. & Kalland, K. H. (1997). Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. Virology 235, 73-81.
64. Thiriart, C., Francotte, M., Cohen, J., Collignon, C., Delers, A., Kummert, S., Molitor, C., Gilles, D., Roelants, P., van Wijnendaele, F. and others (1989). Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120. Journal of Immunology 143, 1832-1836.
65. Venkatesh, L.K. & Chinnadurai, G. (1990). Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology 178, 327-330.
66. Wansink, D. G., Schul, W., van der Kraan, I., van Steensel, B., van Driel, R. & de Jong, L. (1993). Fluorescent labeling of nascent RNA reveals transcription by RNA polymerase II in domains scattered throughout the nucleus. Journal of Cell Biology 122, 283-293.
67. Weichselbraun, I., Farrington, G. K., Rusche, J. R., Böhnlein, E. & Hauber, J. (1992). Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. Journal of Virology 66, 2583-2587.
68. Wolff, B., Cohen, G., Hauber, J., Meshceryakova, D. & Rabeck, C. (1995). Nucelocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Experimental Cell Research 217, 31-41.
69. Zapp, M. L., Hope, T. J., Parslow, T. G. & Green, M. R. (1991). Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proceedings of the National Academy of Sciences, USA 88, 7734-7738.